Repligen
RGEN
#2045
Rank
S$12.03 B
Marketcap
S$213.80
Share price
-0.47%
Change (1 day)
12.28%
Change (1 year)
Categories

Number of shares outstanding for Repligen (RGEN)

Number of shares outstanding as of December 2025 : 56,265,000

According to Repligen 's latest financial reports and stock price the company's current number of shares outstanding is 56,265,000. At the end of 2025 the company had 56,265,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Repligen from 1996 to 2025

Shares Outstanding at the end of each year

Year Shares Outstanding Change
202556.26 M0.37%
202456.05 M0.43%
202355.81 M0.49%
202255.54 M0.43%
202155.3 M4.07%
202053.14 M2.07%
201952.06 M18.65%
201843.88 M0.72%
201743.56 M28.77%
201633.83 M2.69%
201532.94 M0.61%
201432.74 M2.6%
201331.91 M2.52%
201231.13 M1.09%
201130.79 M0.03%
201030.78 M0.09%
200930.75 M-0.17%
200830.8 M-0.47%
200730.95 M1.9%
200630.37 M0.9%
200530.1 M0.13%
200430.06 M0.62%
200329.87 M9.38%
200227.31 M2.53%
200126.64 M0.25%
200026.57 M19.75%
199922.19 M47.96%
199815 M12.5%
199713.33 M-33.33%
199620 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Novavax
NVAX
162,353,000 188.55%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
192,032,000 241.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
99,400,000 76.66%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
1,058,000,000 1,780.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
378,000,000 571.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2,036,000,000 3,518.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
5,685,000,000 10,003.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
155,464,000 176.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
304,268,000 440.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
49,213,000-12.53%๐Ÿ‡บ๐Ÿ‡ธ USA